Autonomix Medical Inc.

NASDAQ

Currency in USD
4.45
+1.70 (+61.82%)

Closed

Jul 29, 2026

Day's Range

3.94
7.21

52 wk Range

0.2000
8.21
Loading

Key Statistics

Symbol

AMIX

Name

Autonomix Medical Inc.

Currency

USD

Exchange

NASDAQ

High

7.21

Low

3.94

Open

‪4.32‬

Last

‪4.45‬

Market Cap

1.49M

Volume

3.80M

Average Volume

1.38M

Dividend Yield

‪0.00%‬

Change

1.70

Percent Change

61.82

Timestamp

2026-07-29

Close

4.45

Today Range Start

‪3.94‬

Today Range End

‪7.21‬

52 Week Range Start

‪0.2000‬

52 Week Range End

‪8.21‬

Type

Stocks

Country

United States

Compliance - AMIX - Autonomix Medical Inc.

Compliance

Status

COMPLIANT

Report Date

2025-02-18

Business Screen

COMPLIANT

Financial Screen

COMPLIANT

Compliant Revenue

‪99.00%‬

Non Compliant Revenue

‪0.00%‬

Questionable Revenue

‪1.00%‬

Securities To Market Cap Ratio

‪1.00%‬

Debt To Market Cap Ratio

‪3.00%‬

Historical Data - AMIX - Autonomix Medical Inc.

Historical Data

TimeOpenHighLowCloseVolume

No data available

Market Cap - AMIX - Autonomix Medical Inc.

Market Cap

2026-07-28

1.49M

2026-07-27

1.51M

2026-07-24

1.58M

2026-07-23

1.90M

2026-07-22

2.16M

2026-07-21

2.32M

2026-07-20

2.29M

2026-07-17

2.41M

2026-07-16

2.67M

2026-07-15

2.78M

Splits - AMIX - Autonomix Medical Inc.

Splits

2026-06-24

1-for-21 split (21)

Earnings - AMIX - Autonomix Medical Inc.

Earnings

DateTimeEPS EstimateEPS ActualDifferenceSurprise PRC
2026-02-11--9.66-7.562.10‪-21.74%‬
2025-11-12--31.50-28.982.52‪-8.00%‬
2025-08-13--20.58-22.47-1.89‪+9.18%‬
2025-05-29--25.94-15.5410.40‪-40.09%‬
2025-02-13--50.40-30.6619.74‪-39.17%‬

Balance Sheet - AMIX - Autonomix Medical Inc.

Balance Sheet

Period Ending2026-03-312025-03-312024-03-312023-03-31
ExpandAssets
7.60M9.80M9.40M865K
ExpandLiabilities
1.70M1.70M1.77M221K
ExpandShareholders Equity
5.89M8.09M7.62M644K

Cash Flow - AMIX - Autonomix Medical Inc.

Cash Flow

Period Ending2026-03-312025-03-312024-03-312023-03-31
ExpandOperating Activities
----
ExpandInvesting Activities
----
ExpandFinancing Activities
----
End Cash Position7M9.13M8.60M865K
Income Tax Paid----
Interest Paid----
Free Cash Flow-12.29M-8.27M-6.66M-1.85M

Income Statement - AMIX - Autonomix Medical Inc.

Income Statement

Period Ending2026-03-312025-03-312024-03-312023-03-31
Sales0000
Cost of Goods----
Gross Profit----
ExpandOperating Expense
----
Operating Income-17.03M-11.58M-7.47M-1.99M
ExpandNon-Operating Interest
----
Other Income Expense---8M-
Pre Tax Income-16.71M-11.41M-15.42M-1.99M
Income Tax0000
Net Income-16.71M-11.41M-15.42M-1.99M
EPS Basic--6.46-21-1.884664
EPS Diluted--6.46-21-1.884664
Basic Shares Outstanding-1.76M731.31K1.05M
Diluted Shares Outstanding-1.76M731.31K1.05M
Ebit-16.71M-11.23M-15.34M-1.99M
Ebitda-16.70M-11.05M-7.26M-1.99M
Net Income Continuous Operations-16.71M-11.41M-15.42M-1.99M
Minority Interests----
Preferred Stock Dividends----

Recommendations - AMIX - Autonomix Medical Inc.

Recommendations

DateStrong BuyBuyHoldSellStrong Sell
Jul 202611000
Jun 202611000
May 2026-----
Apr 2026-----

Profile - AMIX - Autonomix Medical Inc.

Profile

Mic Code

XNCM

Sector

Healthcare

Industry

Medical Devices

Employees

8


Autonomix Medical Inc. is a medical device company developing precision nerve-targeted therapies to treat diseases involving the peripheral nervous system. Its first-in-class platform technology features a proprietary catheter-based microchip sensing array that detects and differentiates neural signals with ultra-high sensitivity and on-site data processing, surpassing existing technologies. This enables real-time identification of target nerves, followed by proprietary radio frequency ablation to precisely disable them, and verification of treatment efficacy in a minimally invasive transvascular procedure. Initially focused on pain management for pancreatic cancer patients, the platform addresses unmet needs in chronic pain by offering targeted denervation as an alternative to opioids or invasive methods. With potential applications across cardiology, hypertension, pulmonology, gastroenterology, and interventional pain management, Autonomix Medical Inc. equips physicians with innovative tools for accurate diagnosis and therapy. Headquartered in The Woodlands, Texas, the company advances this breakthrough system protected by a global intellectual property portfolio.

Profile Details

Type

Common Stock

Address

21 Waterway Avenue

City

The Woodlands

State

TX

Zip

77380

Country

United States

Phone

713 588 6150

Related news

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.
Autonomix Medical Inc. (AMIX - NASDAQ) Price Today | UA Finance